Hiroshi Jokaji

Publications (2)5.77 Total impact

• Article: Haemostatic and fibrinolytic parameters in septic patients with leukopenia or leukocytosis

  Masanori Saito, Hidesaku Asakura, Hiroshi Jokaji, Chika Uotani, Ichiro Kumabashiri, Eriko Morishita, Masahide Yamazaki, Tomotaka Yoshida, Keiji Aoshima, Tamotsu Matsuda
  [show abstract] [hide abstract]
  ABSTRACT: Induction of leukocytopenia by cytotoxic drugs protects against the generalized Shwartzman reaction induced by endotoxin. To elucidate the relationship between leukocyte number and in haemostatic and fibrinolytic disturbances in human sepsis, we studied 32 septic patients with abnormal leukocyte counts. Twenty patients had sepsis in the setting of leukopenia after chemotherapy for haematological malignancies. Twelve patients with leukocytosis developed sepsis associated with benign disorders. Concentrations of thrombin-antithrombin III complex (TAT), plasminogen activator inhibitor-1 (PAI-1) and plasma thrombomodulin (TM) in the leukocytosis group of (12.0 ± 11.0, 40.2 ± 27.0 and 5.5 ± 2.3 ng/ml, respectively) were significantly elevated compared to the leukopenia group of (3.8 ± 2.3, 18.0 ± 15.0 and 3.1 ± 1.0 ng/ml, respectively) and controls (3.3 ± 0.4, 10.5 ± 5.3, 3.0 ± 0.5 ng/ml, respectively). On the other hand, there were no significant differences in these values between leukopenia group and controls. Thus leucocytes may play important roles in thrombin generation, PAI-1 release and injury to endothelial cells.
  European Journal Of Haematology 04/2009; 54(3):176 - 179. · 2.61 Impact Factor
• Article: Plasminogen Activator Inhibitor in Plasma and Arteriosclerosis

  TAMOTSU MATSUDA, ERIKO MORISHITA, HIROSHI JOKAJI, MASANORI SAITO, ICHIRO KUMABASHIRI, HIDESAKU AKAKURA, CHIKA UOTANI, MASAHIDE YAMAZAKI
  Annals of the New York Academy of Sciences 12/2006; 748(1):394 - 398. · 3.15 Impact Factor